ABSTRACT
The incidence of ectopic pregnancy (EP) has increased in recent years, owing to causes such as pelvic inflammatory diseases and assisted reproductive technologies (ART). The present study reported a case of a 33-year-old nulliparous woman with a history of previous ectopic pregnancies, who underwent pelvic ultrasound in August 2022, which revealed a double EP including a cervical pregnancy and a tubal stump pregnancy. Despite known risk factors and elevated beta-human chorionic gonadotropin (ß-hCG) levels, a conservative approach, utilizing multiple doses of systemic methotrexate (MTX) injections, was employed to preserve fertility at the Regional Perinatal Center in Aktobe, Kazakhstan. Treatment efficacy was monitored through ß-hCG levels and ultrasound imaging, with successful resolution of both EPs and preservation of reproductive function. The present case highlighted the safety and efficacy of MTX therapy in managing complex EP presentations, emphasizing the necessity of individualized treatment approaches in reproductive medicine, particularly in terms of preserving fertility in patients undergoing ART. Multiple high doses of MTX injections were beneficial for pregnancy with two distinct regions, fetal cardiac activity, and elevated serum ß-hCG level. Further research is required to explore optimal treatment strategies for EP, considering patient-specific factors and treatment goals.
Subject(s)
Methotrexate , Pregnancy, Ectopic , Reproductive Techniques, Assisted , Humans , Female , Methotrexate/therapeutic use , Methotrexate/administration & dosage , Methotrexate/adverse effects , Pregnancy , Adult , Pregnancy, Ectopic/drug therapy , Abortifacient Agents, Nonsteroidal/therapeutic use , Abortifacient Agents, Nonsteroidal/administration & dosageABSTRACT
Varicocele can reduce male fertility potential through various oxidative stress mechanisms. Excessive production of reactive oxygen species may overwhelm the sperm's defenses against oxidative stress, damaging the sperm chromatin. Sperm DNA fragmentation, in the form of DNA strand breaks, is recognized as a consequence of the oxidative stress cascade and is commonly found in the ejaculates of men with varicocele and fertility issues. This paper reviews the current knowledge regarding the association between varicocele, oxidative stress, sperm DNA fragmentation, and male infertility, and examines the role of varicocele repair in alleviating oxidative-sperm DNA fragmentation in these patients. Additionally, we highlight areas for further research to address knowledge gaps relevant to clinical practice.
Subject(s)
DNA Fragmentation , Infertility, Male , Oxidative Stress , Spermatozoa , Varicocele , Humans , Male , Varicocele/physiopathology , Varicocele/complications , Oxidative Stress/physiology , Infertility, Male/etiology , Infertility, Male/genetics , Infertility, Male/physiopathology , Infertility, Male/metabolism , Spermatozoa/physiology , Spermatozoa/metabolism , Reactive Oxygen Species/metabolismABSTRACT
No increased risk of postpartum major depression (PPMD) was reported in women conceiving through assisted reproductive technologies (ART). However, ART may be associated with a higher risk of parenting difficulties in women with PPMD. In 359 women with a PPMD admitted to a Mother-Baby Unit (MBU), ART-women (4.2%) showed a 5-fold higher rate of parenting difficulties than those with spontaneous pregnancy (73.33% vs. 35.17%, multivariate ORa = 5.09 [1.48-17.48] p = 0.01). Specific support for mother-child relationship should be implemented in ART-women with PPMD.
ABSTRACT
PURPOSE: To assess the relationship between clinical and semen characteristics and assisted reproductive technology (ART) outcomes with different birth weight (BW) categories in a cohort of infertile men. MATERIALS AND METHODS: Data from 1,063 infertile men were analyzed. Patients with BW ≤2,500, 2,500-4,000, and ≥4,000 g were considered as having low BW (LBW), normal BW (NBW), and high BW (HBW), respectively. Testicular volume (TV) was assessed with a Prader orchidometer. Serum hormones were measured in all cases. Semen analyses were categorized based on 2021 World Health Organization reference criteria. Sperm DNA fragmentation (SDF) was tested in every patient and considered pathological for SDF >30%. ART outcomes were available for 282 (26.5%) patients. Descriptive statistics and logistic regression analyses detailed the association between semen parameters and clinical characteristics and the defined BW categories. RESULTS: Of all, LBW, NBW, and HBW categories were found in 79 (7.5%), 807 (76.0%), and 177 (16.5%) men, respectively. LBW men had smaller TV, presented higher follicle-stimulating hormone (FSH) but lower total testosterone levels compared to other groups (all p<0.01). Sperm progressive motility (p=0.01) and normal morphology (p<0.01) were lower and SDF values were higher (all p<0.01) in LBW compared to other groups. ART pregnancy outcomes were lower in LBW compared to both NBW and HBW categories (26.1% vs. 34.5% vs. 34.5%, p=0.01). At multivariable logistic regression analysis, LBW was associated with SDF >30% (odd ratio [OR] 3.7; p<0.001), after accounting for age, Charlson Comorbidity Index (CCI), FSH, and TV. Similarly, LBW (OR 2.2; p<0.001), SDF >30% (OR 2.9; p<0.001) and partner's age (OR 1.3; p=0.001) were associated with negative ART outcomes, after accounting for the same predictors. CONCLUSIONS: LBW was associated with impaired clinical and semen characteristics in infertile men compared to both NBW and HBW. SDF and ART outcomes were significantly worse in the LBW group.
ABSTRACT
Objetivo: Analizar la relación entre el índice de Masa Corporal en mujeres y los resultados obtenidos en las técnicas de reproducción asistida. Método: Se llevó a cabo un diseño no experimental, transversal, descriptivo y correlacional, mediante un análisis de datos secundarios en varias clínicas de reproducción asistida en España. Se analizaron 3.273 historias clínicas de mujeres sometidas a fecundación in vitro entre 2015-2018. Se recogieron datos de filiación e inicio del tratamiento, datos antropométricos, antecedentes personales, enfermedades actuales, esterilidad primaria, esterilidad secundaria, así como los parámetros referentes a los resultados tras tratamiento de reproducción asistida. El análisis estadístico se realizó mediante el software SPSS-V19.0. Resultados: 798 mujeres (24,42%) tenían un IMC ≥25. Las mujeres con sobrepeso consiguieron un menor número de ovocitos recuperados y fecundados, así como menor número de embriones obtenidos. Las mujeres con peso normal consiguieron un menor número de óvulos maduros y las mujeres con bajo peso presentaron una menor tasa de fecundación. Conclusiones: Se ha encontrado que los resultados obtenidos en las técnicas de reproducción asistida tienen relación con el índice de Masa Corporal de las mujeres. (AU)
Objective: To analyze the relationship between the Body Mass Index in women and the results obtained in assisted reproductive techniques. Methods: A non-experimental, cross-sectional, descriptive and correlational design was carried out through an analysis of secondary data in several assisted reproduction clinics from Spain. 3,273 medical records of women undergoing In Vitro Fertilization between 2015 and 2018 were analyzed. Data on affiliation and treatment initiation, anthropometric data, personal history, current diseases, primary and secondary infertility, as well as the reference parameters to the results after the assisted reproduction treatment were collected. The statistical analysis was performed using SPSS v19.0 software. Results: A total of 798 women (24.42%) had a BMI values ≥ 25. The overweight women achieved a lower number of oocytes retrieved and fertilized, as well as fewer embryos obtained. The women with normal weight achieved a lower number of mature oocytes and those with low weight had a lower fertilization rate. Conclusions: It has been found that the results obtained in assisted reproductive techniques are related to women's Body Mass Index. (AU)
Subject(s)
Humans , Female , Body Mass Index , Reproductive Techniques, Assisted , Cross-Sectional Studies , Epidemiology, Descriptive , Spain , Treatment OutcomeABSTRACT
BACKGROUND: To detect the predictive value of beta human chorionic gonadotropin (ß-hCG) levels 16 days post embryo transfer (ET) regarding detection of an ectopic pregnancy (EP) in assisted reproductive technology (ART) cycles. MATERIALS AND METHODS: In this cross-sectional study, we reviewed the database of Royan Institute from January 2011 to December 2014 and from January 2017 to December 2019 retrospectively. All cases with positive ß-hCG levels sixteen days after ET were screened (n=4149). The pregnancies with oocyte or embryo donation and the multiple pregnancies based on the first ultrasound were excluded. All eligible singleton pregnancies with documented serum ß-hCG levels at Royan institute laboratory (n=765) were included and then classified according to the type of pregnancy: EP (n=189) or non-EP (n=576). The data of the treatment cycle was extracted from the patients' files. A receiver operating characteristic (ROC) curve was used to detect the predictive power of the first measurement of ß-hCG level in distinguishing EP from ongoing pregnancy in the ART and intrauterine insemination (IUI) cycles separately. Sensitivity, specificity, area under the ROC curve and 95% confidence intervals (CI) were calculated for each of the estimates. RESULTS: The mean levels of ß-hCG 16 days after ET were remarkably higher in the ongoing pregnancy group than the EP group (1592.35 ± 87 IU/L vs. 369.69 ± 50.61 IU/L, P<0.001). The ß-hCG thresholds predictive of ongoing pregnancy were 278 IU/L as the most suitable cut-off to predict viable pregnancy with a sensitivity of 72.8%, a specificity of 67.5%, a positive predictive value of 77.8%, standard error of 0.02, and a confidence interval of 73.8- 81.7%. However, this relationship was not found in IUI cycles. CONCLUSION: Based on these findings, if ß-hCG levels 16 days after ET are below 278 IU/l, close follow-up is recommended, until either the diagnosis of EP or miscarriage is established.
ABSTRACT
Epidemiologists indicate that about half of the couple's infertility cases are due to a male factor. Despite this, the role of andrologists or endocrinologists in assisted reproductive technique (ART) centers is still underestimated. According to our literature review, this reduces the chance of a thorough clinical evaluation of the male partners, which, sometimes consists only in a mere semen analysis, usually performed by laboratory technicians. A more complete diagnostic process could lead to the identification of potentially treatable causes of infertility, the recognition of diseases that require immediate treatment, and to the discovery of genetic diseases and, therefore, transmissible to the offspring. It can also increase the success rate of ART resulting in less psychological and financial burden for both public health resources and infertile couples. The presence of medical personnel with andrological and endocrinological skills in the ART centers represents the first step in creating 'precision medicine'. We hope that the guidelines of the various scientific societies will clearly contemplate this possibility.
ABSTRACT
Objetivo: analisar a legislação ordinária e o regramento deontológico vigentes no Brasil sobre os processos assistidos de procriação humana, considerando a investigação das repercussões no âmbito dos direitos das partes envolvidas. Metodologia: revisão bibliográfica e documental, por meio do método dedutivo, buscando a construção de apontamentos críticos quanto ao atual estado regulatório dos processos assistidos de procriação humana. Resultados: o conjunto regulatório agrega previsões normativas gerais relacionadas ao Código Civil, à Lei de Biossegurança e previsões deontológicas. Juntas, trazem conteúdos de relevância, mas, por vezes, insuficientes e não adequados às diversas circunstâncias que podem envolver a prática da fertilização in vitro, da gestação por substituição e da reprodução post mortem. Conclusão: propõe-se, a partir dos direitos reprodutivos da mulher e da autonomia das partes, a reconsideração parcial do conteúdo regulado pelo regramento deontológico, bem como a atualização das normas ordinárias.
Objective:to analyze the legislation and deontological rules in force in Brazil regarding artificial insemination in humans, considering the impact on the rights of those involved. Methods: bibliographic and documentary study using the deductive method, with the aim of critically commenting on the current state of legislation on artificial insemination in humans. Results: the legal framework includes general normative provisions related to the Civil Code, the Biosafety Law and deontological provisions. Together, they provide relevant content but are sometimes insufficient and inadequate for the various circumstances that may be associated with the practice of in vitro fertilization, surrogacy, and postmortem reproduction. Conclusion: based on women's reproductive rights and the autonomy of the parties, it is proposed to reconsider some of the contents regulated in the deontological provisions and to update the legislation.
Objetivo: analizar la legislación ordinaria y las normas deontológicas vigentes en Brasil sobre los procesos de procreación humana asistida, considerando la investigación de las repercusiones en el alcance de los derechos de las partes involucradas. Metodología: revisión bibliográfica y documental, a través del método deductivo, buscando la construcción de apuntes críticos respecto al estado normativo actual de los procesos de procreación humana asistida. Resultados: el conjunto normativo agrega disposiciones normativas generales relacionadas con el Código Civil, la Ley de Bioseguridad y disposiciones deontológicas. En conjunto, aportan contenidos relevantes, pero en ocasiones insuficientes y no adecuados a las distintas circunstancias que puede conllevar la prácticade la fecundación in vitro, la gestación subrogada y la reproducción post mortem. Conclusión: se propone, con base en los derechos reproductivos de la mujer y la autonomía de las partes, la reconsideración parcial del contenido regulado por las reglas deontológicas, así como la actualización de las normas ordinarias.
ABSTRACT
This study reviewed recent advances in the use of Doppler ultrasonography for the management and prediction of female infertility outcomes of assisted reproductive technology (ART). Color or power Doppler and three-dimensional power Doppler ultrasound can be used to measure vessels near the ovaries, uterus, and endometrium to assess blood flow. Increased blood flow and reduced resistance to the ovaries, uterus, and endometrium are associated with improved pregnancy outcomes, and their measurement has been suggested as a key factor in ART procedural outcomes. Perifollicular vascularity indices can help predict oocyte quality and maturity. Likewise, endometrial and uterine vascularity could be associated with endometrial receptivity and may assist with embryo transfer timing and pregnancy outcome predictions. With the advancement of Doppler ultrasound technology, this highly potent examination will be used more widely in routine clinical settings for the treatment of female infertility.
ABSTRACT
The provision of care that is responsive to the preferences, needs and values of gamete donors is key to improving their recruitment and ensuring the functioning of gamete banks. This qualitative study aimed to explore gamete donors' experiences about the facilitating and constraining human and system factors to donor-centred healthcare delivery in gamete banks. It is based on 20 semi-structured interviews with oocyte and sperm donors, recruited at the Portuguese Public Bank of Gametes, conducted from November 2017 to February 2019. Deductive content analysis was performed using the software NVivo12, following the patient-centred infertility care model. Interviewees identified facilitating factors mostly related with the human dimension of care (i.e. careful and available attitude and behaviours of health professionals, as well as their good communication skills and emotional support). Constraining factors were predominantly identified at the system level (i.e. insufficient information provision, poor coordination, and integration). Lack of privacy emerged simultaneously as a human and a system constraining factor (i.e. physical discomfort during medical-technical acts or gamete collection). There is room for improving clinical practice and the organisation of healthcare services within a context where the competence and attitude of, and relationship with, the staff are highly valued.
Subject(s)
Oocyte Donation , Semen , Humans , Male , Oocyte Donation/psychology , Tissue Donors/psychology , Attitude , OocytesABSTRACT
Objective:To investigate the influential factors of adverse pregnancy outcomes in women with subchorionic hematoma.Methods:A total of 101 women with subchorionic hematoma who received treatment in the People's Hospital of Xinjiang Uygur Autonomous Region from January 2017 to June 2020 were included in this study. They were divided into a control group and an adverse pregnancy outcome group according to whether there was an adverse pregnancy outcome. The epidemiological characteristics, hematoma characteristics observed on ultrasound images, and pregnancy outcomes were compared between the two groups.Results:There was no significant difference in the number of women who used assisted reproductive technology between the control and adverse pregnancy outcome groups [6 (8.0%) vs. 8 (30.7%), χ2 = 8.38, P = 0.004]. There was a significant difference in hematoma volume between adverse pregnancy outcome and control groups [(4.12 ± 0.61) mL vs. (6.36 ± 0.87) mL, t = 6.73, P = 0.009]. There was a significant difference in the number of patients who had obstetric complications between control and adverse pregnancy outcome groups [11 (14.7%) vs. 16 (61.5%), χ2 = 21.66, P = 0.001]. There was a significant difference in the number of patients who had hematomas located at the edge of the placenta between the control and adverse pregnancy outcome groups [15 (20.0%) vs. 12 (46.2%), χ2 = -4.81, P = 0.001]. Conclusion:Women who use assisted reproductive technology for pregnancy, have obstetric complications, or have a subchorionic hematoma with hematoma at the edge of the placenta are more likely to experience a miscarriage. Therefore, women of childbearing age should actively treat the primary disease and be alert to the occurrence of placental abruption.
ABSTRACT
Objective:To investigate the effect of body mass index (BMI) on the first in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment for young women of childbearing age (20-35 years old) with tubal factor infertility.Methods:A retrospective analysis was conducted on the clinical data of 747 patients who underwent assisted reproductive technology (IVF/ICSI) treatment for the first time at the Reproductive Medicine Center of the First People′s Hospital of Changde City from January 1, 2019 to September 30, 2021. The patients were aged 20-35 years old and all received controlled ovarian hyperstimulation treatment using a long-term follicular protocol. Patients were divided into four groups based on their BMI values during physical examinations before assisted pregnancy treatment: the weight loss group [body mass index (BMI)<18.5 kg/m 2 in 72 cases], the normal weight group (18.5 kg/m 2≤BMI<24 kg/m 2 in 455 cases), the super recombination group (24 kg/m 2≤BMI<28 kg/m 2 in 161 cases), and the obesity group (BMI≥28 kg/m 2 in 59 cases). The differences in relevant indicators during controlled ovarian hyperstimulation treatment and pregnancy outcomes after fresh embryo transfer were analyzed among each group. Resultsl:There were no statistically significant differences in age, infertility years, primary/secondary infertility ratio, basal follicle stimulating hormone levels, and sinus follicle count among the lean, normal weight, overweight, and obese groups (all P>0.05). There were no statistically significant differences in the duration of gonadotropin (Gn) administration, the number of follicles with a diameter of ≥14 mm on the trigger day, the level of estrogen on the trigger day, the number of retrieved eggs, the number of double pronuclei, the rate of cyst formation, the rate of transplantation, and the rate of whole embryo cryopreservation among the four groups (all P>0.05). The total amount of Gn was found to be (2 374.5±892.5)U in the lean group, (2 643.8±1 213.5)U in the normal weight group, (2 950.5±1 156.5)U in the super recombinant group, and (2 949.8±1 030.5)U in the obese group, with a statistically significant difference ( P=0.001). The number of excellent embryos was (3.06±2.50) in the lean group, (2.96±2.16) in the normal weight group, (2.45±1.96) in the super recombinant group, and (2.39±2.03) in the obese group, with a statistically significant difference ( P=0.015). The embryo free rate among the four groups significantly increased with increasing BMI, and the difference was statistically significant ( P=0.039). There was no statistically significant difference in the number of embryos transferred, biochemical pregnancy rate, clinical pregnancy rate, embryo implantation rate, multiple pregnancy rate, early abortion rate, mid-term abortion rate, and live birth rate among the four groups (all P>0.05). Conclusions:In patients with simple tubal factor infertility who receive long-term follicular phase assisted fertilization treatment, an increase in BMI can significantly increase the dosage of Gn, reduce the number of excellent embryos, and increase the rate of no embryos. Although there is currently no statistical difference in various indicators of pregnancy outcomes after fresh embryo transfer among different BMI groups, there is a risk of an increase in early or mid-term miscarriage rates as BMI increases.
ABSTRACT
Objective:To analyze the impact of intrauterine infusion of autologous peripheral blood mononuclear cells (PBMCs) and enriched platelet plasma (PRP) on pregnancy outcomes in patients with recurrent implantation failure (RIF).Methods:A total of 96 patients with repeated implantation failures who underwent frozen embryo cycles at Hunan Provincial Maternal and Child Health Care Hospital from March 2021 to June 2023 were selected and randomly divided into a control group (19 cases), PBMCs group (31 cases), and PRP group (46 cases). The control group did not receive uterine cavity infusion treatment; Intrauterine perfusion of PBMCs in the PBMCs group; The uterine cavity of the PRP group was infused with PRP. We compared the general situation, endometrial thickness on the day of conversion, endometrial thickness on the day of transplantation, embryo implantation rate, and clinical pregnancy rate among three groups.Results:There was no statistically significant difference in age, body mass index (BMI), years of infertility, menstrual cycle, serum basal follicle stimulating hormone (FSH), basal estradiol (E 2), number of transfer cycles, number of transferred embryos, and number of high-quality embryos among the three groups (all P>0.05). There was no statistically significant difference in endometrial thickness on the conversion day among the control group, PRP group, and PBMCs group (all P>0.05). The endometrial thickness on the day of transplantation in the PRP group was greater than that in the control group and PBMCs group (all P<0.05), and there was no statistically significant difference in endometrial thickness on the day of transplantation between the control group and PBMCs group (all P>0.05). The embryo implantation rate and clinical pregnancy rate of the PRP group and PBMCs group were higher than those of the control group, and the difference was statistically significant (all P<0.05). There was no statistically significant difference in embryo implantation rate and clinical pregnancy rate between the PRP group and the PBMCs group (all P>0.05). The patients did not experience any adverse reactions such as infection, abdominal pain, or vaginal bleeding during intrauterine infusion therapy. Conclusions:Infusing autologous PBMCs or PRP into the uterine cavity before re embryo transfer in RIF patients can significantly improve embryo implantation rate and clinical pregnancy rate, and can improve assisted pregnancy outcomes; Intrauterine infusion of autologous PRP has no significant advantage over PBMCs in improving clinical pregnancy outcomes in patients with RIF; But it is more beneficial for improving the thickness of the endometrium.
Subject(s)
Fertility Preservation , Neoplasms , Humans , Australia , Neoplasms/therapy , Guidelines as TopicABSTRACT
OBJECTIVES: To compare age-adjusted all-cause and CVD mortality, relative to the general female population, for women registered for fertility treatment who received it and those who did not. DESIGN: Prospective cohort study; analysis of Monash IVF clinical registries data, 1975-2018, linked with National Death Index mortality data. PARTICIPANTS: All women who registered for fertility treatment at Monash IVF (Melbourne, Victoria), 1 January 1975 - 1 January 2014, followed until 31 December 2018. MAIN OUTCOME MEASURES: Standardised mortality ratios (SMRs) for all-cause and CVD mortality, for women who did or did not undergo fertility treatment; SMRs stratified by area-level socio-economic disadvantage (SEIFA Index of Relative Socioeconomic Disadvantage [IRSD]) and (for women who underwent treatment), by stimulated cycle number and mean oocytes/cycle categories. RESULTS: Of 44 149 women registered for fertility treatment, 33 520 underwent treatment (66.4%), 10 629 did not. After adjustment for age, both all-cause (SMR, 0.58; 95% CI, 0.54-0.62) and CVD mortality (SMR, 0.41; 95% CI, 0.32-0.53) were lower than for the general female population. All-cause mortality was similar for women registered with Monash IVF who did (SMR, 0.55; 95% CI, 0.50-0.60) or did not undergo fertility treatment (SMR, 0.63; 95% CI, 0.56-0.70). The SMR was lowest for both treated and untreated women in the fifth IRSD quintile (least disadvantage), but the difference was statistically significant only for untreated women. CVD mortality was lower for registered women who underwent fertility treatment (SMR, 0.29; 95% CI, 0.19-0.43) than for those who did not (SMR, 0.58; 95% CI, 0.42-0.81). CONCLUSION: Fertility treatment does not increase long term all-cause or CVD mortality risk. Lower mortality among women registered for fertility treatment probably reflected their lower socio-economic disadvantage.
Subject(s)
Cardiovascular Diseases , Female , Humans , Cardiovascular Diseases/therapy , Prospective Studies , Fertility , Cause of Death , RegistriesABSTRACT
OBJECTIVE: To comprehensively describe current preimplantation genetic testing for aneuploidy (PGT-A) practices and management of non-euploid embryos in Canada. METHODS: This was a cross-sectional study utilizing an online survey distributed by email to all medical directors of fertility clinics with independent in vitro fertilization (IVF) embryology laboratories. The survey was designed to determine practice patterns regarding PGT-A usage; PGT-A reference laboratory, platform, and thresholds for classifying embryos; and management of embryos classified as mosaic, inconclusive, or aneuploid. RESULTS: Twenty-five medical directors (69%) participated in the survey. The majority of clinics (91%) offered PGT-A screening, with 45% of clinics offering PGT-A as routine screening. The majority of clinics (90%) that offered PGT-A received mosaicism data; 61% of these clinics had transferred mosaic embryos, and 94% would transfer mosaic embryos. Clinics that performed ≥1000 IVF cycles annually were more likely to have transferred mosaic embryos (100% vs. 45.5%; P = 0.043). The mean percentage of IVF cycles using PGT-A was lower in clinics that had transferred mosaic embryos (12.3% vs. 30.4%; P = 0.033). Only 1 clinic had transferred an aneuploid embryo, but 2 other clinics would consider this option. The majority of clinics (61%) that receive mosaicism data would recommend noninvasive prenatal testing (NIPT) following mosaic embryo transfer, with 22% of clinics indicating that this would be the only genetic test offered. CONCLUSION: We report significant practice variation in PGT-A and management of non-euploid embryos across Canada and highlight areas where consensus should be encouraged.